
Recent Stories
Next →
India’s D2C boom is more than a retail story. Here’s why thematic investing could be your smartest bet yet.

The Gensol–BluSmart saga is a crash course in what not to ignore as a retail investor. Read here to know more.

Unusual signals—from lipstick to lattes—offering a satirical take on how the economy shows up in everyday behavior.

This article decodes the math behind Washington’s tariff strategy, and evaluates how different Indian sectors may be impacted.

India Hit by 26% US Tariff; Markets Slide as Global Trade Tensions Escalate.

The U.S. is targeting India’s trade surplus with new tariffs. The high-value pharmaceutical sector now risks major disruption.
